Shiina T, Suzuki Y, Horii K, Sawamura T, Yuki N, Horii Y
J Physiol Sci. 2024; 74(1):26.
PMID: 38654149
PMC: 11036717.
DOI: 10.1186/s12576-024-00916-5.
Wyss M, Heuer C, Herwerth M
Neural Regen Res. 2023; 19(6):1206-1211.
PMID: 37905866
PMC: 11467927.
DOI: 10.4103/1673-5374.386405.
Oda K, Miyamoto S, Kodera R, Wada J, Shikata K
J Diabetes Investig. 2022; 14(2):205-220.
PMID: 36308062
PMC: 9889613.
DOI: 10.1111/jdi.13930.
Lim S, Lee S
Molecules. 2022; 27(16).
PMID: 36014340
PMC: 9414776.
DOI: 10.3390/molecules27165088.
Lopez X, Palacios-Prado N, Guiza J, Escamilla R, Fernandez P, Vega J
Proc Natl Acad Sci U S A. 2021; 118(32).
PMID: 34301850
PMC: 8364136.
DOI: 10.1073/pnas.2108967118.
Neurotransmitters responsible for purinergic motor neurotransmission and regulation of GI motility.
Sanders K, Mutafova-Yambolieva V
Auton Neurosci. 2021; 234:102829.
PMID: 34146957
PMC: 8575072.
DOI: 10.1016/j.autneu.2021.102829.
Purinergic Receptors Crosstalk with CCR5 to Amplify Ca Signaling.
Horioka M, Ceraudo E, Lorenzen E, Sakmar T, Huber T
Cell Mol Neurobiol. 2020; 41(5):1085-1101.
PMID: 33216235
PMC: 8159800.
DOI: 10.1007/s10571-020-01002-1.
Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Jacobson K, IJzerman A, Muller C
Biochem Pharmacol. 2020; 187:114311.
PMID: 33130128
PMC: 8081756.
DOI: 10.1016/j.bcp.2020.114311.
Regulating quantal size of neurotransmitter release through a GPCR voltage sensor.
Zhang Q, Liu B, Li Y, Yin L, Younus M, Jiang X
Proc Natl Acad Sci U S A. 2020; 117(43):26985-26995.
PMID: 33046653
PMC: 7604499.
DOI: 10.1073/pnas.2005274117.
Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets.
Filippin K, de Souza K, de Araujo Junior R, Torquato H, Dias D, Parisotto E
Purinergic Signal. 2019; 16(1):1-15.
PMID: 31863258
PMC: 7166233.
DOI: 10.1007/s11302-019-09684-z.
100 Years of Suramin.
Wiedemar N, Hauser D, Maser P
Antimicrob Agents Chemother. 2019; 64(3).
PMID: 31844000
PMC: 7038244.
DOI: 10.1128/AAC.01168-19.
POM-1 inhibits P2 receptors and exhibits anti-inflammatory effects in macrophages.
Pimenta-Dos-Reis G, Torres E, Quintana P, Vidal L, Dos Santos B, Lin C
Purinergic Signal. 2017; 13(4):611-627.
PMID: 29022161
PMC: 5714851.
DOI: 10.1007/s11302-017-9588-x.
Suramin Inhibits Osteoarthritic Cartilage Degradation by Increasing Extracellular Levels of Chondroprotective Tissue Inhibitor of Metalloproteinases 3.
Chanalaris A, Doherty C, Marsden B, Bambridge G, Wren S, Nagase H
Mol Pharmacol. 2017; 92(4):459-468.
PMID: 28798097
PMC: 5588548.
DOI: 10.1124/mol.117.109397.
K 7/M channels as targets for lipopolysaccharide-induced inflammatory neuronal hyperexcitability.
Tzour A, Leibovich H, Barkai O, Biala Y, Lev S, Yaari Y
J Physiol. 2016; 595(3):713-738.
PMID: 27506492
PMC: 5285726.
DOI: 10.1113/JP272547.
Critical role of gap junction communication, calcium and nitric oxide signaling in bystander responses to focal photodynamic injury.
Cali B, Ceolin S, Ceriani F, Bortolozzi M, Agnellini A, Zorzi V
Oncotarget. 2015; 6(12):10161-74.
PMID: 25868859
PMC: 4496347.
DOI: 10.18632/oncotarget.3553.
Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.
Naviaux J, Wang L, Li K, Bright A, Alaynick W, Williams K
Mol Autism. 2015; 6:1.
PMID: 25705365
PMC: 4334917.
DOI: 10.1186/2040-2392-6-1.
Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds.
Croci R, Pezzullo M, Tarantino D, Milani M, Tsay S, Sureshbabu R
PLoS One. 2014; 9(3):e91765.
PMID: 24622391
PMC: 3951423.
DOI: 10.1371/journal.pone.0091765.
Purinergic signalling in the reproductive system in health and disease.
Burnstock G
Purinergic Signal. 2013; 10(1):157-87.
PMID: 24271059
PMC: 3944041.
DOI: 10.1007/s11302-013-9399-7.
Purinergic signalling in the urinary tract in health and disease.
Burnstock G
Purinergic Signal. 2013; 10(1):103-55.
PMID: 24265069
PMC: 3944045.
DOI: 10.1007/s11302-013-9395-y.
Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model.
Naviaux R, Zolkipli Z, Wang L, Nakayama T, Naviaux J, Le T
PLoS One. 2013; 8(3):e57380.
PMID: 23516405
PMC: 3596371.
DOI: 10.1371/journal.pone.0057380.